Status
Conditions
Treatments
About
In a observational study the second-generation laryngeal masks LMA Supreme and Ambu AuraGain are investigated.
Full description
After approval from the local ethics committee, data were collected in a prospective, non- randomised study over a three-month period. When contra-indications for laryngeal mask use were absent anaesthesiologists used either Supreme (Teleflex Medical GmbH, Germany) or Gain (Ambu GmbH, Germany). Endpoints were the success rate and time to insertion.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
364 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal